The proteomics analysis of CAF-derived EVs identified that annexin A6 plays a pivotal role in the drug resistance of gastric cancer cells via the activation of β1 integrin and the downstream intracellular signaling pathways, involving focal adhesion kinase (FAK) and the yes-associated protein (YAP). Here, PTK2 is linked to gastric cancer.